| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_53810094575edc7546de6511f90fa6b0 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H17-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7052
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H17-00 |
| filingDate |
2012-07-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0aaad5f64abf747e68078594787e76d3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1e84069d2f7197902a88a0abd2ea5fa5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4fb40191313904b3255f39f16898a902
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b61cdd401404f665d82d4f5e65c69512 |
| publicationDate |
2014-06-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-2736915-A1 |
| titleOfInvention |
New crystalline forms of tulathromycin |
| abstract |
The present invention describes new crystalline forms I, II and III of tulathromycin, new tulathromycin salts and processes for their preparation. |
| priorityDate |
2011-07-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |